0001741638-21-000002.txt : 20210622
0001741638-21-000002.hdr.sgml : 20210622
20210622165845
ACCESSION NUMBER: 0001741638-21-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210622
DATE AS OF CHANGE: 20210622
EFFECTIVENESS DATE: 20210622
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc.
CENTRAL INDEX KEY: 0001808805
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-403839
FILM NUMBER: 211036025
BUSINESS ADDRESS:
STREET 1: 425 PONTIUS AVE N, STE 202
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-333-2001
MAIL ADDRESS:
STREET 1: 425 PONTIUS AVE N, STE 202
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III
DATE OF NAME CHANGE: 20200408
D
1
primary_doc.xml
X0708
D
LIVE
0001808805
Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
SEATTLE
WA
WASHINGTON
98109
206-333-2001
DELAWARE
ARYA Sciences Acquisition Corp III
Corporation
true
2020
Sujal
Patel
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Executive Officer
Director
Parag
Mallick
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Executive Officer
Director
Vijay
Pande
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Director
Farzad
Nazem
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Director
Matthew
Posard
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Director
Anna
Mowry
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Executive Officer
Melissa
Epperly
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Director
Michael
Altman
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Director
Matthew
S.
McIlwain
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Director
Nicholas
Nelson
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Executive Officer
Subra
Sankar
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Executive Officer
Matthew
Murphy
c/o Nautilus Biotechnology, Inc.
425 PONTIUS AVE N, STE 202
Seattle
WA
WASHINGTON
98109
Executive Officer
Other
Decline to Disclose
- 06b
false
2021-06-09
false
true
false
0
Jefferies LLC
2347
None
None
520 Madison Avenue
New York
NY
NEW YORK
10022
All States
false
Goldman Sachs & Co. LLC
361
None
None
200 West Street
New York
NY
NEW YORK
10282-2198
All States
false
200000000
200000000
0
false
38
2000000
0
$1,000,000 in commission fees were paid to each Goldman Sachs & Co. LLC and Jefferies LLC.
0
false
Nautilus Biotechnology, Inc.
/s/ Sujal Patel
Sujal Patel
Chief Executive Officer
2021-06-22